Akèy › Kansè pwostat › Texas
Etid klinik pou Kansè pwostat nan Texas
115 etid pou Kansè pwostat ap chèche patisipan nan sit nan Texas.
Vil nan Texas
- Houston76 etid
- Dallas36 etid
- San Antonio28 etid
- Austin15 etid
- Fort Worth9 etid
- Richardson6 etid
- The Woodlands6 etid
- Irving4 etid
- League City4 etid
- Sugar Land4 etid
- Arlington3 etid
Tèks ofisyèl etid la (Anglè)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Urology Austin, Austin
Ap rekriteFaz 4
Laj 18 ak plis · Gason · Mizajou Sep 29, 2026 · NCT07569926A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics, LLC (START), San Antonio
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06095089Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Urology Austin, Austin
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06496256DESTINY-PANTUMOUR04
- Research Site, Dallas
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- NEXT Oncology, Austin
- MD Anderson Cancer Center, Houston
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06800313Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
- M D Anderson Cancer Center, Houston
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07377006Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Houston
Ap rekriteFaz 1/2
Laj 18 a 130 · Gason · Mizajou Sep 25, 2026 · NCT07181161A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06172478A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Texas Oncology - Central/South Texas ( Site 8003), Austin
- Texas Oncology - DFW ( Site 8001), Dallas
- Texas Oncology - Gulf Coast ( Site 8002), Houston
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06136650Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
- The University of Texas M. D. Anderson Cancer Center, Houston
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06759701A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Dallas-Fort Worth, Fort Worth
- NEXT Houston, Houston
- NEXT Oncology, San Antonio
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07719361This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center - William P. Clements, Jr., University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07028853A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Mary Crowley Cancer Research, Dallas
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07570979A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- The Center for Cancer and Blood Disorders, Arlington
- University of Texas Southwestern Medical Center, Dallas
- Renovatio Clinical, Houston
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07213674Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Texas Oncology, Dallas
- Urology San Antonio, San Antonio
Ap rekriteFaz 2/3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06780670Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Urology Austin, Lakeway
- Urology San Antonio, San Antonio
- Woodlands Cancer Institute American Oncology Partners, The Woodlands
Ap rekriteFaz 3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Texas Oncology - DFW (Sammons CC), Dallas
- MD Anderson Cancer Center, Houston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07114601Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)
- MD Anderson Cancer Center, Houston
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Sep 18, 2026 · NCT06085729A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Austin
- Research Site, Austin
- Research Site, Houston
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 18, 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT05011383A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Parkland Health & Hospital System ( Site 0069), Dallas
- UT Southwestern Medical Center ( Site 0039), Dallas
- University of Texas-MD Anderson Cancer Center ( Site 0055), Houston
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT06925737Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- University of Texas MD Anderson Cancer Center, Houston
- Next Oncology - Dallas, Irving
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 15, 2026 · NCT07493512The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- New Experimental Therapeutics - NEXT Oncology, Austin
- Texas Oncology, Bedford
- UT Southwest Simmons Cancer Center, Dallas
- ak 2 plis
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04585750Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Urology Partners of North Texas (UPNT), Arlington
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Urology Austin, PLLC - Research Department, Austin
- Urology Clinics of North Texas, Dallas
- University of Texas Southwestern Medical Center, Dallas
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 11, 2026 · NCT06056830Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 401, Houston
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05997615Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- MD Anderson in The Woodlands, Conroe
- Brooke Army Medical Center, Fort Sam Houston
- UT MD Anderson Cancer Center, Houston
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- UT MD Anderson, Houston
- NEXT Oncology, San Antonio
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06440005A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- SCRI Oncology Partners, Nashville
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 8, 2026 · NCT05800665A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Texas MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics (START), San Antonio
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06465069Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- SCRI at Mary Crowley, Dallas
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07545811A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Urology Clinics Of North Texas, Dallas
- Urology Partners of North Texas (UPNT), Fort Worth
- Houston Metro Urology (HMU), Houston
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07723248Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 2, 2026 · NCT06931340Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Covenant Medical Center-Lakeside, Lubbock
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 2, 2026 · NCT07200830Prostate Active Surveillance Study
- University of Texas Health Science Center, San Antonio, San Antonio
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou Sep 2, 2026 · NCT00756665Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06632977A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- University of Texas Southwestern Medical Center, Dallas
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 31, 2026 · NCT05726292Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Houston
Ap rekriteFaz 1/2
Laj 18 a 99 · Gason · Mizajou Aug 27, 2026 · NCT07590934Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.